{"id":"W2092472911","doi":"10.1016/j.biomaterials.2012.03.023","title":"Therapeutic effect of orally administered microencapsulated oxaliplatin for colorectal cancer","year":2012,"lang":"en","type":"article","venue":"Biomaterials","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":43,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Institute of Biomedical Imaging and Bioengineering; National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health; Alnylam Pharmaceuticals","keywords":"Oxaliplatin; Colorectal cancer; Medicine; Drug delivery; Gastrointestinal tract; Cancer; Pharmacology; In vivo; Oral administration; Adverse effect; Drug; Oncology; Internal medicine; Materials science; Nanotechnology; Biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001627361,0.0003166068,0.0004210277,0.0002216929,0.0001539611,0.0002302122,0.0001985593,0.0003438386,0.001132158],"category_scores_gemma":[0.0001488261,0.0001832897,0.0002848157,0.0001738761,0.0002921991,0.0002514254,0.0001246361,0.0005363099,0.0001702728],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003168707,"about_ca_system_score_gemma":0.000419259,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001656344,"about_ca_topic_score_gemma":0.001698946,"domain_scores_codex":[0.9998976,0.00002012161,0.00000582029,0.00001920995,0.00001567018,0.00004161179],"domain_scores_gemma":[0.9999398,0.00001624049,0.00001241522,0.000006812635,0.0000055479,0.00001916962],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.005226853,0.0007805745,0.0001988185,0.0001446362,0.00003255677,0.0001021984,0.00005344442,0.0005440414,0.9828904,0.0001334504,0.0001881046,0.009704985],"study_design_scores_gemma":[0.0002882662,0.006142639,0.001905633,0.000005056995,0.00008607397,0.000118682,0.0000265187,0.001174731,0.9885914,0.00001805561,0.001633864,0.000009173923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962087,0.001978215,0.0005550735,0.00007022939,0.00008999385,0.00003645242,0.00009942732,0.00004585643,0.0009160858],"genre_scores_gemma":[0.9976839,0.0006527354,0.0004652984,0.00002053566,0.00001612369,0.00001822435,0.00007259182,0.000007949036,0.00106249],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001656344,"threshold_uncertainty_score":0.003787458,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02315836411872257,"score_gpt":0.3010808897662177,"score_spread":0.2779225256474951,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}